Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.

Journal article

Feldmann M. et al, (2020), Lancet, 395, 1407 - 1409

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Journal article

Robinson PC. et al, (2020), The lancet rheumatology

A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.

Journal article

Marrinan SL. et al, (2018), Mov disord, 33, 329 - 332

Mutant Mice With Calcium-Sensing Receptor Activation Have Hyperglycemia That Is Rectified by Calcilytic Therapy.

Journal article

Babinsky VN. et al, (2017), Endocrinology, 158, 2486 - 2502

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.

Journal article

Richards DB. et al, (2015), N engl j med, 373, 1106 - 1114

Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis

Journal article

Sahota T. et al, (2015), Cpt: pharmacometrics & systems pharmacology, 4, 116 - 126

Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals.

Journal article

Chamberlain SR. et al, (2012), Psychopharmacology (berl), 224, 501 - 509

Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498.

Journal article

Nathan PJ. et al, (2012), J clin pharmacol, 52, 1456 - 1467

Load More